Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 37 | 14 | 23 | 234 | 27 |
| Gross Profit | 37 | 14 | 23 | 234 | 27 |
| Operating Expenses | 23,417 | 25,344 | 22,985 | 18,193 | 20,866 |
| Operating Income | -23,380 | -25,330 | -22,962 | -17,959 | -20,839 |
| Interest Expense | 110 | 295 | 171 | 169 | 167 |
| Other Income | 14 | 14 | 11 | 61 | 48 |
| Pre-tax Income | -23,476 | -25,611 | -23,122 | -18,067 | -20,958 |
| Net Income Continuous | -23,476 | -25,611 | -23,122 | -18,067 | -20,958 |
| Net Income | $-23,476 | $-25,611 | $-23,122 | $-18,067 | $-20,958 |
| EPS Basic Total Ops | -0.16 | -0.16 | -0.16 | -0.13 | -0.15 |
| EPS Basic Continuous Ops | -0.16 | -0.17 | -0.16 | -0.13 | -0.15 |
| EPS Diluted Total Ops | -0.16 | -0.16 | -0.16 | -0.13 | -0.15 |
| EPS Diluted Continuous Ops | -0.16 | -0.17 | -0.16 | -0.13 | -0.15 |
| EBITDA(a) | $-23,246 | $-25,210 | $-22,844 | $-17,902 | $-20,788 |